microRNA information: hsa-miR-152-3p

SectionIDlink
Mature name: hsa-miR-152-3pmiRbase
Accession: MIMAT0000438miRbase
Precursor name: hsa-mir-152 miRbase
Precursor accession: MI0000462miRbase
Symbol: MIR152HGNC
RefSeq ID: NR_029687GenBank
Sequence: UCAGUGCAUGACAGAACUUGG



Reported expression in cancers: hsa-miR-152-3p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-152-3p

cervical and endocervical cancerupregulation"MiR-152 was upregulated to the greatest extent and ......"26515145
hsa-miR-152-3p

colorectal cancerdownregulation"Accumulating evidence showed that microRNA-152 miR ......"26820128
hsa-miR-152-3p

gastric cancerdownregulation"Our previous studies have revealed that miR-148a a ......"21205300
hsa-miR-152-3p

gastric cancerdownregulation"Our results showed decreased expression of miR-152 ......"25119599
hsa-miR-152-3p

glioblastomadownregulation"Our results proved that miR-152 was down-regulated ......"25218589
hsa-miR-152-3p

liver cancerdownregulation"miR-152 expression was detected using real-time qu ......"24998573qPCR
hsa-miR-152-3p

lung squamous cell cancerdownregulation"Serum miR 152 miR 148a miR 148b and miR 21 as nove ......"25501703qPCR
hsa-miR-152-3p

lung squamous cell cancerdownregulation"Decreased plasma let 7c and miR 152 as noninvasive ......"26309587Reverse transcription PCR
hsa-miR-152-3p

thyroid cancerdownregulation"We found that miR-146-5p miR-221-5p miR-222-3p miR ......"27586203



Reported cancer pathway affected by hsa-miR-152-3p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-152-3p

colorectal cancerApoptosis pathway"miR 152 functions as a tumor suppressor in colorec ......"26820128
hsa-miR-152-3p

glioblastomaApoptosis pathway"MiR 152 functions as a tumor suppressor in gliobla ......"25218589
hsa-miR-152-3p

liver cancerApoptosis pathway"Effects of miR 152 on cell growth inhibition motil ......"24998573Western blot
hsa-miR-152-3p

ovarian cancerApoptosis pathway"MiR 152 and miR 185 co contribute to ovarian cance ......"23318422



Reported cancer prognosis affected by hsa-miR-152-3p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-152-3p

bladder cancermalignant trasformation"Analyses in human urothelial cells identify methyl ......"23867826
hsa-miR-152-3p

bladder cancerpoor survival; recurrence"We performed genome-wide serum miRNA analysis by M ......"24961907
hsa-miR-152-3p

breast cancertumorigenesis"Microarray technology was used to evaluate miRNA p ......"25393370
hsa-miR-152-3p

breast cancermetastasis"DNA methylation and not H3K4 trimethylation dictat ......"27475839
hsa-miR-152-3p

cervical and endocervical cancerdrug resistance"Hypoxia inducible miR 152 suppresses the expressio ......"26515145Western blot; Luciferase
hsa-miR-152-3p

colorectal cancerstaging; metastasis; cell migration; progression"miR 152 functions as a tumor suppressor in colorec ......"26820128
hsa-miR-152-3p

endometrial cancermalignant trasformation"Expression profiling of normal and malignant endom ......"20028871
hsa-miR-152-3p

endometrial cancertumorigenesis"miR 152 is a tumor suppressor microRNA that is sil ......"21868754Cell proliferation assay; Cell Proliferation Assay
hsa-miR-152-3p

esophageal cancerdrug resistance"Differentially expressed miRNAs between ESCC patho ......"26445467
hsa-miR-152-3p

gastric cancermotility"miR 152 suppresses gastric cancer cell proliferati ......"25119599
hsa-miR-152-3p

glioblastomacell migration; poor survival; progression"MiR 152 functions as a tumor suppressor in gliobla ......"25218589
hsa-miR-152-3p

liver cancermotility; malignant trasformation; staging; tumor size; progression; tumorigenesis; worse prognosis"Effects of miR 152 on cell growth inhibition motil ......"24998573Western blot
hsa-miR-152-3p

lung squamous cell cancerstaging; metastasis; differentiation"Decreased plasma let 7c and miR 152 as noninvasive ......"26309587
hsa-miR-152-3p

lung squamous cell cancermetastasis"MiR 152 regulates metastases of non small cell lun ......"26823738Luciferase
hsa-miR-152-3p

lung squamous cell cancerstaging"The aim of this study was to determine whether cir ......"27461630
hsa-miR-152-3p

ovarian cancerpoor survival; drug resistance; tumorigenesis"Altered expression of miR 152 and miR 148a in ovar ......"21971665Cell proliferation assay; Cell Proliferation Assay
hsa-miR-152-3p

ovarian cancermotility"Regulation of colony stimulating factor 1 expressi ......"22909061
hsa-miR-152-3p

ovarian cancerdrug resistance"MiR 152 and miR 185 co contribute to ovarian cance ......"23318422
hsa-miR-152-3p

ovarian cancerdrug resistance"Hybridization was carried out on miRNA microarray ......"24805828
hsa-miR-152-3p

prostate cancermalignant trasformation; cell migration; staging"miR 152 controls migration and invasive potential ......"23460133Western blot; Luciferase
hsa-miR-152-3p

prostate cancermetastasis; poor survival; recurrence"MicroRNA profiling of novel African American and C ......"25004396
hsa-miR-152-3p

sarcomapoor survival; worse prognosis"Potential values of microRNA152 miR-152 as a serum ......"26464682
hsa-miR-152-3p

thyroid cancermalignant trasformation"We found that miR-146-5p miR-221-5p miR-222-3p miR ......"27586203



Reported gene related to hsa-miR-152-3p

miRNAcancergenereportingPUBMED
hsa-miR-152-3p

breast cancerDNMT1"mRNA and protein expression profile of DNMT1 impli ......"27475839
hsa-miR-152-3p

endometrial cancerDNMT1"Epigenetic silencing documented in miR-152 was con ......"21868754
hsa-miR-152-3p

liver cancerDNMT1"Our results showed that the expression of microRNA ......"20578129
hsa-miR-152-3p

liver cancerDNMT1"Furthermore Western blotting showed that the miR-1 ......"24998573
hsa-miR-152-3p

ovarian cancerDNMT1"MiR 152 and miR 185 co contribute to ovarian cance ......"23318422
hsa-miR-152-3p

prostate cancerDNMT1"There appeared to be a reciprocal regulatory relat ......"25004396
hsa-miR-152-3p

gastric cancerHLA-G"Long non coding RNA HOTAIR promotes HLA G expressi ......"26187665
hsa-miR-152-3p

gastric cancerHLA-G"TGF β induces HLA G expression through inhibiting ......"26627200
hsa-miR-152-3p

colorectal cancerCASP3"Function assays demonstrated that restoring the ex ......"26820128
hsa-miR-152-3p

gastric cancerCD151"miR 152 suppresses gastric cancer cell proliferati ......"25119599
hsa-miR-152-3p

prostate cancerCDC37"Predicted interaction between miR-152 and mRNAERBB ......"23958847
hsa-miR-152-3p

breast cancerCDH1"In this investigation we attempt to elucidate the ......"27475839
hsa-miR-152-3p

endometrial cancerCOPZ2"Epigenetic silencing documented in miR-152 was con ......"21868754
hsa-miR-152-3p

ovarian cancerCSF1"By mutations in putative miRNA targets in CSF-1 mR ......"22909061
hsa-miR-152-3p

ovarian cancerCSF2"Regulation of colony stimulating factor 1 expressi ......"22909061
hsa-miR-152-3p

endometrial cancerE2F3"We identified E2F3 MET and Rictor as novel candida ......"21868754
hsa-miR-152-3p

cervical and endocervical cancerERBB3"Hypoxia inducible miR 152 suppresses the expressio ......"26515145
hsa-miR-152-3p

gastric cancerHOTAIR"Long non coding RNA HOTAIR promotes HLA G expressi ......"26187665
hsa-miR-152-3p

glioblastomaKLF4"Mechanistic investigations defined Krüppel-like f ......"25218589
hsa-miR-152-3p

lung squamous cell cancerNRP1"MiR 152 regulates metastases of non small cell lun ......"26823738
hsa-miR-152-3p

colorectal cancerPIK3R1"Mechanistic investigations defined phosphoinositid ......"26820128
hsa-miR-152-3p

colorectal cancerPIK3R3"miR 152 functions as a tumor suppressor in colorec ......"26820128
hsa-miR-152-3p

breast cancerRASSF1"Male miR-152 and miR-497 upregulation and RASSF1A ......"25393370
hsa-miR-152-3p

breast cancerRASSF5"Male miR-152 and miR-497 upregulation and RASSF1A ......"25393370
hsa-miR-152-3p

endometrial cancerRICTOR"We identified E2F3 MET and Rictor as novel candida ......"21868754
hsa-miR-152-3p

glioblastomaSCPEP1"In addition XIST and miR-152 are probably in the s ......"25578780
hsa-miR-152-3p

liver cancerTNFRSF6B"miR-152 may act as a tumor suppressor miRNA by als ......"24998573
hsa-miR-152-3p

cervical and endocervical cancerWNT1"Hypoxia inducible miR 152 suppresses the expressio ......"26515145
hsa-miR-152-3p

glioblastomaXIST"Knockdown of long non coding RNA XIST exerts tumor ......"25578780



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-152-3p
ECHS1
9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; OV; PAAD; PRAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.138; TCGA BRCA -0.06; TCGA CESC -0.133; TCGA ESCA -0.204; TCGA HNSC -0.136; TCGA OV -0.114; TCGA PAAD -0.19; TCGA PRAD -0.38; TCGA UCEC -0.134
hsa-miR-152-3p
SETDB1
11 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LGG; LIHC; LUAD; OV; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.084; TCGA BRCA -0.091; TCGA CESC -0.077; TCGA ESCA -0.112; TCGA KIRP -0.084; TCGA LGG -0.12; TCGA LIHC -0.087; TCGA LUAD -0.101; TCGA OV -0.091; TCGA STAD -0.082; TCGA UCEC -0.072
hsa-miR-152-3p
UCP3
12 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD
MirTarget
TCGA BLCA -0.248; TCGA BRCA -0.122; TCGA CESC -0.191; TCGA ESCA -0.287; TCGA KIRC -0.159; TCGA KIRP -0.192; TCGA LGG -0.068; TCGA LIHC -0.222; TCGA LUAD -0.306; TCGA LUSC -0.254; TCGA PRAD -0.386; TCGA STAD -0.207
hsa-miR-152-3p
SKP1
10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUSC; OV; PRAD; SARC
MirTarget
TCGA BLCA -0.091; TCGA BRCA -0.064; TCGA CESC -0.083; TCGA COAD -0.15; TCGA HNSC -0.114; TCGA LIHC -0.068; TCGA LUSC -0.058; TCGA OV -0.11; TCGA PRAD -0.099; TCGA SARC -0.099
hsa-miR-152-3p
MAGIX
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; SARC
MirTarget
TCGA BLCA -0.487; TCGA BRCA -0.279; TCGA CESC -0.197; TCGA ESCA -0.661; TCGA HNSC -0.142; TCGA LGG -0.069; TCGA LUSC -0.217; TCGA PAAD -0.564; TCGA PRAD -0.568; TCGA SARC -0.202
hsa-miR-152-3p
NR2C2AP
11 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LIHC; OV; PAAD; PRAD; SARC; THCA
MirTarget
TCGA BLCA -0.118; TCGA BRCA -0.224; TCGA HNSC -0.193; TCGA KIRP -0.176; TCGA LGG -0.113; TCGA LIHC -0.185; TCGA OV -0.088; TCGA PAAD -0.132; TCGA PRAD -0.418; TCGA SARC -0.121; TCGA THCA -0.247
hsa-miR-152-3p
ABCD3
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.175; TCGA BRCA -0.152; TCGA CESC -0.136; TCGA COAD -0.209; TCGA ESCA -0.457; TCGA LUSC -0.184; TCGA SARC -0.064; TCGA STAD -0.333; TCGA UCEC -0.113
hsa-miR-152-3p
RIBC1
11 cancers: BLCA; BRCA; CESC; KIRP; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.165; TCGA BRCA -0.189; TCGA CESC -0.267; TCGA KIRP -0.104; TCGA LUSC -0.28; TCGA OV -0.145; TCGA PAAD -0.431; TCGA PRAD -0.358; TCGA SARC -0.191; TCGA STAD -0.159; TCGA UCEC -0.216
hsa-miR-152-3p
MAF1
9 cancers: BLCA; BRCA; CESC; HNSC; LIHC; PAAD; PRAD; SARC; THCA
MirTarget
TCGA BLCA -0.058; TCGA BRCA -0.121; TCGA CESC -0.056; TCGA HNSC -0.066; TCGA LIHC -0.174; TCGA PAAD -0.175; TCGA PRAD -0.289; TCGA SARC -0.073; TCGA THCA -0.069
hsa-miR-152-3p
NEURL4
12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD
MirTarget
TCGA BLCA -0.13; TCGA BRCA -0.17; TCGA CESC -0.106; TCGA HNSC -0.136; TCGA KIRC -0.211; TCGA KIRP -0.076; TCGA LGG -0.123; TCGA LIHC -0.103; TCGA LUAD -0.241; TCGA LUSC -0.091; TCGA PAAD -0.389; TCGA PRAD -0.212
hsa-miR-152-3p
PRR15
9 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LIHC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.79; TCGA BRCA -0.416; TCGA CESC -0.552; TCGA ESCA -1.392; TCGA KIRP -0.253; TCGA LIHC -0.332; TCGA THCA -2.173; TCGA STAD -0.345; TCGA UCEC -0.355
hsa-miR-152-3p
MDM4
15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.199; TCGA BRCA -0.126; TCGA CESC -0.131; TCGA ESCA -0.198; TCGA HNSC -0.091; TCGA KIRC -0.208; TCGA KIRP -0.24; TCGA LGG -0.097; TCGA LIHC -0.12; TCGA LUAD -0.249; TCGA LUSC -0.144; TCGA PAAD -0.171; TCGA PRAD -0.167; TCGA SARC -0.138; TCGA STAD -0.314
hsa-miR-152-3p
SIRT7
12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; THCA
MirTarget
TCGA BLCA -0.182; TCGA BRCA -0.245; TCGA COAD -0.17; TCGA ESCA -0.127; TCGA HNSC -0.229; TCGA KIRP -0.153; TCGA LGG -0.095; TCGA LIHC -0.162; TCGA LUAD -0.143; TCGA PAAD -0.273; TCGA PRAD -0.419; TCGA THCA -0.128
hsa-miR-152-3p
KLHL17
13 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD
MirTarget
TCGA BLCA -0.133; TCGA BRCA -0.298; TCGA CESC -0.106; TCGA HNSC -0.494; TCGA KIRP -0.262; TCGA LGG -0.148; TCGA LIHC -0.231; TCGA LUAD -0.303; TCGA LUSC -0.261; TCGA PAAD -0.539; TCGA PRAD -0.72; TCGA THCA -0.421; TCGA STAD -0.246
hsa-miR-152-3p
NPEPL1
10 cancers: BLCA; BRCA; CESC; HNSC; LGG; LIHC; LUAD; PAAD; PRAD; SARC
MirTarget
TCGA BLCA -0.209; TCGA BRCA -0.24; TCGA CESC -0.081; TCGA HNSC -0.174; TCGA LGG -0.109; TCGA LIHC -0.153; TCGA LUAD -0.271; TCGA PAAD -0.311; TCGA PRAD -0.518; TCGA SARC -0.113
hsa-miR-152-3p
CLCN6
9 cancers: BLCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; PRAD; SARC
MirTarget
TCGA BLCA -0.093; TCGA CESC -0.1; TCGA ESCA -0.205; TCGA KIRC -0.272; TCGA LIHC -0.098; TCGA LUAD -0.264; TCGA LUSC -0.307; TCGA PRAD -0.065; TCGA SARC -0.128
hsa-miR-152-3p
PRKCZ
12 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.19; TCGA BRCA -0.228; TCGA ESCA -0.187; TCGA HNSC -0.148; TCGA KIRC -0.17; TCGA LUAD -0.168; TCGA LUSC -0.266; TCGA OV -0.092; TCGA PAAD -0.434; TCGA PRAD -0.32; TCGA STAD -0.16; TCGA UCEC -0.171
hsa-miR-152-3p
ORMDL1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; THCA; STAD
MirTarget
TCGA BLCA -0.08; TCGA BRCA -0.082; TCGA CESC -0.058; TCGA COAD -0.142; TCGA ESCA -0.12; TCGA HNSC -0.129; TCGA KIRP -0.15; TCGA LGG -0.067; TCGA LIHC -0.099; TCGA LUAD -0.104; TCGA PAAD -0.133; TCGA PRAD -0.253; TCGA THCA -0.089; TCGA STAD -0.239
hsa-miR-152-3p
NCKIPSD
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; THCA
MirTarget
TCGA BLCA -0.11; TCGA BRCA -0.079; TCGA CESC -0.143; TCGA COAD -0.136; TCGA ESCA -0.176; TCGA HNSC -0.083; TCGA LUAD -0.105; TCGA PAAD -0.231; TCGA PRAD -0.058; TCGA SARC -0.269; TCGA THCA -0.172
hsa-miR-152-3p
PPP1R9A
11 cancers: BLCA; CESC; ESCA; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC
MirTarget
TCGA BLCA -0.746; TCGA CESC -1.25; TCGA ESCA -1.064; TCGA LGG -0.077; TCGA LIHC -0.197; TCGA LUAD -0.194; TCGA LUSC -0.827; TCGA PAAD -0.35; TCGA PRAD -0.161; TCGA THCA -0.171; TCGA UCEC -0.17
hsa-miR-152-3p
USP48
9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LIHC; LUSC; SARC; STAD
MirTarget
TCGA BLCA -0.062; TCGA CESC -0.061; TCGA ESCA -0.129; TCGA HNSC -0.078; TCGA KIRC -0.101; TCGA LIHC -0.054; TCGA LUSC -0.122; TCGA SARC -0.054; TCGA STAD -0.148
hsa-miR-152-3p
NLK
9 cancers: BLCA; BRCA; CESC; ESCA; LUAD; PAAD; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.132; TCGA BRCA -0.122; TCGA CESC -0.1; TCGA ESCA -0.24; TCGA LUAD -0.058; TCGA PAAD -0.244; TCGA PRAD -0.094; TCGA STAD -0.127; TCGA UCEC -0.094
hsa-miR-152-3p
ZDHHC23
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.214; TCGA BRCA -0.128; TCGA CESC -0.125; TCGA COAD -0.214; TCGA ESCA -0.53; TCGA KIRC -0.231; TCGA LUAD -0.256; TCGA LUSC -0.133; TCGA PAAD -0.192; TCGA PRAD -0.202; TCGA SARC -0.643; TCGA STAD -0.422; TCGA UCEC -0.149
hsa-miR-152-3p
MAGI1
9 cancers: BLCA; CESC; ESCA; KIRC; LGG; LUAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.354; TCGA CESC -0.316; TCGA ESCA -0.569; TCGA KIRC -0.356; TCGA LGG -0.075; TCGA LUAD -0.124; TCGA SARC -0.29; TCGA STAD -0.341; TCGA UCEC -0.136
hsa-miR-152-3p
ZNF3
12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LIHC; OV; PAAD; PRAD; UCEC
MirTarget
TCGA BLCA -0.141; TCGA BRCA -0.128; TCGA COAD -0.134; TCGA ESCA -0.128; TCGA KIRC -0.08; TCGA KIRP -0.091; TCGA LGG -0.07; TCGA LIHC -0.07; TCGA OV -0.079; TCGA PAAD -0.128; TCGA PRAD -0.279; TCGA UCEC -0.08
hsa-miR-152-3p
DMPK
10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC
MirTarget
TCGA BLCA -0.172; TCGA BRCA -0.163; TCGA CESC -0.105; TCGA HNSC -0.131; TCGA KIRP -0.185; TCGA LIHC -0.102; TCGA LUAD -0.239; TCGA LUSC -0.314; TCGA PAAD -0.394; TCGA SARC -0.4
hsa-miR-152-3p
PNPLA6
11 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA
MirTarget
TCGA BLCA -0.127; TCGA BRCA -0.157; TCGA CESC -0.076; TCGA HNSC -0.091; TCGA LIHC -0.101; TCGA LUAD -0.156; TCGA LUSC -0.159; TCGA PAAD -0.292; TCGA PRAD -0.195; TCGA SARC -0.2; TCGA THCA -0.222
hsa-miR-152-3p
ZNF784
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA
MirTarget
TCGA BLCA -0.217; TCGA BRCA -0.148; TCGA ESCA -0.117; TCGA HNSC -0.191; TCGA KIRP -0.116; TCGA LUAD -0.138; TCGA LUSC -0.105; TCGA PAAD -0.421; TCGA PRAD -0.426; TCGA THCA -0.128
hsa-miR-152-3p
DENND4C
9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; SARC; STAD
MirTarget
TCGA BLCA -0.115; TCGA CESC -0.101; TCGA COAD -0.148; TCGA ESCA -0.319; TCGA KIRC -0.154; TCGA LUAD -0.063; TCGA LUSC -0.206; TCGA SARC -0.13; TCGA STAD -0.273
hsa-miR-152-3p
DGCR8
10 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC
RAID
TCGA BLCA -0.127; TCGA BRCA -0.077; TCGA KIRC -0.11; TCGA KIRP -0.118; TCGA LGG -0.082; TCGA LIHC -0.07; TCGA LUAD -0.128; TCGA PAAD -0.206; TCGA PRAD -0.154; TCGA SARC -0.076
hsa-miR-152-3p
SNRPD1
10 cancers: BRCA; COAD; HNSC; KIRP; LGG; LIHC; OV; PRAD; THCA; STAD
MirTarget
TCGA BRCA -0.115; TCGA COAD -0.148; TCGA HNSC -0.281; TCGA KIRP -0.107; TCGA LGG -0.123; TCGA LIHC -0.177; TCGA OV -0.17; TCGA PRAD -0.347; TCGA THCA -0.115; TCGA STAD -0.236
hsa-miR-152-3p
CHD1
9 cancers: CESC; COAD; ESCA; KIRC; LGG; LUSC; SARC; THCA; STAD
MirTarget
TCGA CESC -0.071; TCGA COAD -0.17; TCGA ESCA -0.132; TCGA KIRC -0.135; TCGA LGG -0.055; TCGA LUSC -0.092; TCGA SARC -0.059; TCGA THCA -0.059; TCGA STAD -0.252
hsa-miR-152-3p
ATP8A1
9 cancers: CESC; ESCA; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC
MirTarget
TCGA CESC -0.35; TCGA ESCA -1.242; TCGA KIRC -0.221; TCGA LUAD -0.381; TCGA LUSC -0.54; TCGA PRAD -0.2; TCGA SARC -0.263; TCGA STAD -0.451; TCGA UCEC -0.148
hsa-miR-152-3p
GPCPD1
9 cancers: HNSC; KIRC; KIRP; LUAD; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA HNSC -0.086; TCGA KIRC -0.131; TCGA KIRP -0.101; TCGA LUAD -0.157; TCGA LUSC -0.163; TCGA SARC -0.081; TCGA THCA -0.172; TCGA STAD -0.229; TCGA UCEC -0.206





Enriched cancer pathways of putative targets